Form 4: Teradyne Director Sells Shares Under Pre-Arranged 10b5-1 Plan

Mercedes Johnson, a director at Teradyne, sold 625 shares of common stock at $110.04 per share on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Mercedes Johnson, a director at Teradyne, executed a sale of 625 shares of the company's common stock.
• The transaction occurred on December 2, 2024.
• The sale price was $110.04 per share.
• The sale was conducted under a pre-arranged trading plan, specifically a 10b5-1 plan, adopted on February 1, 2024.
• Following the transaction, Ms. Johnson directly owns 14,643 shares of Teradyne common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a pre-planned share sale by a director, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent non-public information.

Comparison to Industry Standards

• Sales by directors under 10b5-1 plans are a common practice across publicly traded companies, including those in the technology sector like Teradyne.
• Companies such as Applied Materials and Lam Research also see similar filings from their directors and officers.
• The volume of shares sold is relatively small compared to the total outstanding shares of Teradyne, which is typical for these types of transactions.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders, as it is a small transaction by a single director under a pre-arranged plan.

Key Dates

Keywords

Teradyne, insider trading, share sale, Form 4, 10b5-1 plan, director, Mercedes Johnson